# Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone

> **NCT00767637** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 14 (actual)

## Conditions studied

- Hyperphosphatemia
- Dialysis

## Interventions

- **DRUG:** Lanthanum Carbonate (BAY77-1931)

## Key facts

- **NCT ID:** NCT00767637
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2008-10
- **Final completion:** 2008-10
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2014-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00767637

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00767637, "Long-term Treatment on BAY77-1931 (Lanthanum Carbonate) to Measure Lanthanum Concentrations in Bone". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00767637. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*